Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.

[1]  A. Boyde,et al.  Activated Invariant NKT Cells Regulate Osteoclast Development and Function , 2011, The Journal of Immunology.

[2]  Y. Kohno,et al.  Differential effects of tumour necrosis factor‐α and interleukin‐12 on isopentenyl pyrophosphate‐stimulated interferon‐γ production by cord blood Vγ9 T cells , 2009, Immunology.

[3]  Asha B. Pillai,et al.  Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease. , 2009, Blood.

[4]  M. Swain,et al.  Natural killer T cells regulate the homing of chemokine CXC receptor 3‐positive regulatory T cells to the liver in mice , 2009, Hepatology.

[5]  S. Balk,et al.  Natural Killer T Cell–Based Cancer Immunotherapy , 2006, Clinical Cancer Research.

[6]  M. Bonneville,et al.  Human Vγ9Vδ2 T cells : promising new leads for immunotherapy of infections and tumors , 2006 .

[7]  T. Fujisawa,et al.  Natural killer T cell‐mediated antitumor immune responses and their clinical applications , 2006, Cancer science.

[8]  P. Christadoss,et al.  Cooperation of Invariant NKT Cells and CD4+CD25+ T Regulatory Cells in the Prevention of Autoimmune Myasthenia1 , 2005, The Journal of Immunology.

[9]  M. Bonneville,et al.  Vγ9Vδ2 T Cell Response to Colon Carcinoma Cells1 , 2005, The Journal of Immunology.

[10]  G. Tiegs,et al.  α-Galactosylceramide-Induced Liver Injury in Mice Is Mediated by TNF-α but Independent of Kupffer Cells1 , 2005, The Journal of Immunology.

[11]  B. Moser,et al.  Professional Antigen-Presentation Function by Human γδ T Cells , 2005, Science.

[12]  M. Bonneville,et al.  Sensing cell stress and transformation through Vγ9Vδ2 T cell-mediated recognition of the isoprenoid pathway metabolites , 2005 .

[13]  Xianzhu Wu,et al.  Oral Tolerance to Nickel Requires CD4+ Invariant NKT Cells for the Infectious Spread of Tolerance and the Induction of Specific Regulatory T Cells1 , 2004, The Journal of Immunology.

[14]  G. Giaccone,et al.  The immunoregulatory role of CD1d-restricted natural killer T cells in disease. , 2004, Clinical immunology.

[15]  G. Giaccone,et al.  Polarization of Vα24+ Vβ11+ Natural Killer T Cells of Healthy Volunteers and Cancer Patients Using α-Galactosylceramide-loaded and Environmentally Instructed Dendritic Cells , 2003 .

[16]  G. De Libero,et al.  Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells , 2003, The Journal of experimental medicine.

[17]  M. Smyth,et al.  NKT cells: facts, functions and fallacies. , 2000, Immunology today.

[18]  M. Wilhelm,et al.  Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma , 2000 .

[19]  A. Ohta,et al.  alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. , 2000, Cellular immunology.

[20]  T. Iizasa,et al.  Antitumor Cytotoxicity Mediated by Ligand-activated Human Vα24 NKT Cells , 1999 .

[21]  S. Porcelli,et al.  CD1d-restricted Recognition of Synthetic Glycolipid Antigens by Human Natural Killer T Cells , 1998, The Journal of experimental medicine.

[22]  M. Kronenberg,et al.  CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution , 1998, The Journal of experimental medicine.

[23]  Hiroshi Sato,et al.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. , 1997, Science.

[24]  S. Balk,et al.  Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells , 1997, The Journal of experimental medicine.

[25]  A. Lanzavecchia,et al.  An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells , 1994, The Journal of experimental medicine.

[26]  H. Koseki,et al.  Dominant expression of a distinctive V14+ T-cell antigen receptor alpha chain in mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Kaufmann,et al.  Primary responses of human T cells to mycobacteria: a frequent set of γ/δ T cells are stimulated by protease‐resistant ligands , 1990 .

[28]  V. Cerundolo,et al.  Harnessing invariant NKT cells in vaccination strategies , 2009, Nature Reviews Immunology.

[29]  M. Bonneville,et al.  Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors. , 2006, Current opinion in immunology.

[30]  G. Tiegs,et al.  Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. , 2005, Journal of immunology.

[31]  M. Bonneville,et al.  V gamma 9V delta 2 T cell response to colon carcinoma cells. , 2005, Journal of immunology.

[32]  M. Bonneville,et al.  Sensing cell stress and transformation through Vgamma9Vdelta2 T cell-mediated recognition of the isoprenoid pathway metabolites. , 2005, Microbes and infection.

[33]  B. Moser,et al.  Professional antigen-presentation function by human gammadelta T Cells. , 2005, Science.

[34]  G. Giaccone,et al.  Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells. , 2003, Cancer research.

[35]  H. Tony,et al.  Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. , 2000, Blood.

[36]  T. Iizasa,et al.  Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. , 1999, Cancer research.

[37]  S. Kaufmann,et al.  Primary responses of human T cells to mycobacteria: a frequent set of gamma/delta T cells are stimulated by protease-resistant ligands. , 1990, European journal of immunology.

[38]  J. Coligan,et al.  A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family. , 1987, Nature.